J. Bain

发表

D 4476 , a cell-permeant inhibitor of CK 1 , suppresses the site-specific phosphorylationandnuclear exclusion of FOXO 1 a

P. Cohen, G. Rena, J. Bain, 2013 .

D4476, a cell‐permeant inhibitor of CK1, suppresses the site‐specific phosphorylation and nuclear exclusion of FOXO1a

P. Cohen, G. Rena, J. Bain, 2004, EMBO reports.

Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study.

S. Moro, A. Brunati, J. Bain, 2004, Biochemistry.

The specificities of protein kinase inhibitors: an update.

P. Cohen, J. Bain, M. Elliott, 2003, The Biochemical journal.

The selectivity of protein kinase inhibitors: a further update.

P. Cohen, J. Arthur, D. Alessi, 2007, The Biochemical journal.

Inhibition of Protein Kinase CK 2 by Condensed Polyphenolic Derivatives . An in Vitro and in Vivo Study †

S. Moro, A. Brunati, J. Bain, 2004 .

Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis.

P. Silver, P. Cohen, B. Perry, 2007, Blood.

angiogenesis a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling ) , is Solenopsis invicta Solenopsin , the alkaloidal component of the fire ant

P. Silver, P. Cohen, B. Perry, 2006 .

BIRB 796 Inhibits All p 38 MAPK Isoforms in Vitro and in Vivo *

J. Bain, A. Cuenda, N. Shpiro, 2005 .

Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.

J. Bain, M. Elliott, L. Cesaro, 2004, Journal of medicinal chemistry.

New 2-bromomethyl-8-substituted-benzo[c]chromen-6-ones. Synthesis and biological properties.

F. Bihel, J. Kraus, J. Boucher, 2005, Bioorganic & medicinal chemistry letters.

New 2-bromomethyl-8-substituted-benzo[c]chromen-6-ones. Synthesis and biological properties.

F. Bihel, J. Kraus, J. Boucher, 2005, Bioorganic & medicinal chemistry letters.

The selectivity of inhibitors of protein kinase CK2: an update.

J. Bain, M. Elliott, L. Pinna, 2008, The Biochemical journal.

Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase.

A. Edelman, B. Frenguelli, D. Hardie, 2005, Cell metabolism.

Synthesis, kinase inhibitory potencies, and in vitro antiproliferative evaluation of new Pim kinase inhibitors.

Stefan Knapp, Panagis Filippakopoulos, Jenny Bain, 2009, Journal of medicinal chemistry.

BIRB796 Inhibits All p38 MAPK Isoforms in Vitro and in Vivo*

Jenny Bain, J. Bain, A. Cuenda, 2005, Journal of Biological Chemistry.

Tetrabromocinnamic Acid (TBCA) and Related Compounds Represent a New Class of Specific Protein Kinase CK2 Inhibitors

S. Moro, J. Bain, M. Elliott, 2007, Chembiochem : a European journal of chemical biology.

Inhibition of RET tyrosine kinase by SU5416.

L. Scapozza, J. Bain, F. Formelli, 2006, Journal of molecular endocrinology.

ATP site-directed inhibitors of protein kinase CK2: an update.

J. Bain, M. Elliott, L. Pinna, 2011, Current topics in medicinal chemistry.

Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.

S. Moro, J. Bain, M. Elliott, 2009, The Biochemical journal.

Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).

D. Fabbro, P. Furet, J. Bain, 2003, The Biochemical journal.

The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1.

Rodolfo Marquez, Jenny Bain, C. Proud, 2005, Immunity.

Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3.

P. Cohen, F. Lang, Dietmar Kuhl, 2004, The Biochemical journal.

Synthesis, Pim kinase inhibitory potencies and in vitro antiproliferative activities of diversely substituted pyrrolo[2,3-a]carbazoles.

P. Cohen, J. Bain, P. Moreau, 2010, Bioorganic & Medicinal Chemistry.